Exponent (EXPO) VP Joseph Sala sells 2,066 shares in open-market trade

Q: What insider transaction did Exponent (EXPO) report for Joseph Sala?

Exponent reported that Group Vice President Joseph Sala executed an open-market sale of 2,066 shares of Common Stock. The transaction occurred on May 13, 2026 , and was reported on a Form 4 insider trading filing with the SEC.

Q: How many Exponent (EXPO) shares did Joseph Sala sell and what are his holdings now?

Joseph Sala sold 2,066 shares of Exponent Common Stock in this Form 4 transaction. After the sale, the filing indicates his direct ownership of Exponent common shares is 0 shares , with no remaining derivative positions reported in this filing.

Q: Was Joseph Sala’s Exponent (EXPO) trade an open-market sale?

Yes. The Form 4 classifies Joseph Sala’s transaction as an open-market sale of Exponent Common Stock. The transaction code is S , described as a sale in open market or private transaction, covering 2,066 shares at $56.66 per share.

Q: Does the Form 4 show any Exponent (EXPO) stock options or derivatives for Joseph Sala?

The Form 4 derivative summary for Joseph Sala is empty , indicating no reportable derivative positions such as stock options or warrants in this particular filing. The only reported activity is the sale of 2,066 Common Stock shares on May 13, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Exponent Inc. Group Vice President Joseph Sala reported an open-market sale of Common Stock. On May 13, 2026, he sold 2,066 shares at $56.66 per share. Following this transaction, the filing shows Sala directly holding 0 shares of Exponent common stock.

Insights

Exponent executive sold 2,066 shares in an open-market trade.

The filing shows Group Vice President Joseph Sala executed a single open-market sale of 2,066 Common Stock shares at $56.66 on May 13, 2026. After the sale, his reported direct holdings in Exponent common stock are 0 shares.

The transaction is a straightforward open-market sale with no associated derivatives or tax-withholding entries in this report. The filing does not provide context on Sala’s broader indirect holdings or prior position, so the significance of this sale relative to his overall exposure cannot be assessed from this data alone.

Insider Trade Summary

Net Seller: 2,066 shares ($117,060)

Net Sell 1 txn

Insider Sala Joseph

Role Group Vice President

Sold 2,066 shs ($117K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,066	$56.66	$117K

Holdings After Transaction: Common Stock — 0 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 2,066 shares Sale price per share: $56.66 per share Net shares transacted: 2,066 shares +1 more

4 metrics

Shares sold 2,066 shares Open-market sale on May 13, 2026

Sale price per share $56.66 per share Common Stock sale by Joseph Sala

Net shares transacted 2,066 shares Net-sell direction in transaction summary

Direct holdings after transaction 0 shares Total shares following transaction

Key Terms

open-market sale, Common Stock, Form 4, net-sell

4 terms

open-market sale financial

"transaction_action is listed as "open-market sale" in the data"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title is identified as "Common Stock" for the transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

net-sell financial

"transactionSummary shows netBuySellDirection as "net-sell""

Form 4 Insider Transactions: What Each Field Means →

05/13/2026 - 08:55 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sala Joseph

(Last)

(First)

(Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK

CALIFORNIA

94025

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Group Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/13/2026		S		2,066	D	$56.66	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	By: Wendy Whitehouse For: Joseph Sala	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Exponent (EXPO) report for Joseph Sala?

Exponent reported that Group Vice President Joseph Sala executed an open-market sale of 2,066 shares of Common Stock. The transaction occurred on May 13, 2026, and was reported on a Form 4 insider trading filing with the SEC.

At what price did Joseph Sala sell Exponent (EXPO) shares?

Joseph Sala sold Exponent Common Stock at an average price of $56.66 per share. This price applies to the 2,066 shares sold in the reported open-market transaction dated May 13, 2026, according to the Form 4 filing.

How many Exponent (EXPO) shares did Joseph Sala sell and what are his holdings now?

Joseph Sala sold 2,066 shares of Exponent Common Stock in this Form 4 transaction. After the sale, the filing indicates his direct ownership of Exponent common shares is 0 shares, with no remaining derivative positions reported in this filing.

Was Joseph Sala’s Exponent (EXPO) trade an open-market sale?

Yes. The Form 4 classifies Joseph Sala’s transaction as an open-market sale of Exponent Common Stock. The transaction code is S, described as a sale in open market or private transaction, covering 2,066 shares at $56.66 per share.

Does the Form 4 show any Exponent (EXPO) stock options or derivatives for Joseph Sala?

The Form 4 derivative summary for Joseph Sala is empty, indicating no reportable derivative positions such as stock options or warrants in this particular filing. The only reported activity is the sale of 2,066 Common Stock shares on May 13, 2026.